Reversion and non-reversion mechanisms of resistance to PARP inhibitor or platinum chemotherapy in BRCA1/2-mutant metastatic breast cancer

Adrienne G. Waks, Ofir Cohen, Bose Kochupurakkal, D. Kim, Connor E. Dunn, Jorge Buendia, Seth A. Wander, Karla Helvie, Maxwell R. Lloyd, Lori Marini, Melissa E. Hughes, Samuel S. Freeman, S. Percy Ivy, Joseph Geradts, Steven J. Isakoff, Patricia LoRusso, Viktor A. Adalsteinsson, Sara M. Tolaney, Ursula A. Matulonis, Ian E. Krop, Alan D. D’Andrea, Eric P. Winer, Nancy U. Lin, Geoffrey I. Shapiro, Nikhil Wagle